@article{db685fe426f3477d8b9b6f41bfbbb899,
title = "Predicting severe outcomes in COVID-19",
keywords = "COVID-19, SARS-CoV-2, Interleukin-6, C reactive protein, Oxygenation, Cytokine, Inflammation, Ventilation",
author = "Brian Lipworth and Rory Chan and Chris Kuo",
note = "Funding Information: Conflicts of interest: B. Lipworth reports grants and personal fees from Sanofi; grants and personal fees from AstraZeneca and Teva; personal fees from Cipla, Glenmark, Cipla, Dr Reddys, Cricassia, Vectura, Thorasys, Nowus, Mylan, and Lupin; and grants, personal fees, and other from Chiesi, outside the submitted work. Son of B. Lipworth is the employee of AstraZeneca. R. Chan has no relevant conflicts of interest. C. R. Kuo reports personal fees from AstraZeneca, personal fees and other from Chiesi, and personal fees from Circassia, outside the submitted work.",
year = "2020",
month = sep,
doi = "10.1016/j.jaip.2020.06.039",
language = "English",
volume = "8",
pages = "2582--2584",
journal = "The Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
publisher = "Elsevier",
number = "8",
}